These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 35919269)

  • 1. Targeting epigenetic modifiers to reprogramme macrophages in non-resolving inflammation-driven atherosclerosis.
    Jin F; Li J; Guo J; Doeppner TR; Hermann DM; Yao G; Dai Y
    Eur Heart J Open; 2021 Sep; 1(2):oeab022. PubMed ID: 35919269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse Epigenetic Regulations of Macrophages in Atherosclerosis.
    Yang H; Sun Y; Li Q; Jin F; Dai Y
    Front Cardiovasc Med; 2022; 9():868788. PubMed ID: 35425818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the histone lysine demethylase KDM4A/JMJD2A as a novel epigenetic target in M1 macrophage polarization induced by oxidized LDL.
    Wang X; Wang S; Yao G; Yu D; Chen K; Tong Q; Ye L; Wu C; Sun Y; Li H; Hermann DM; Doeppner TR; Jin F; Dai Y; Wu J
    Oncotarget; 2017 Dec; 8(70):114442-114456. PubMed ID: 29383092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix stiffness regulates macrophage polarization in atherosclerosis.
    Wang Y; Shi R; Zhai R; Yang S; Peng T; Zheng F; Shen Y; Li M; Li L
    Pharmacol Res; 2022 May; 179():106236. PubMed ID: 35483516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage polarization: the epigenetic point of view.
    Van den Bossche J; Neele AE; Hoeksema MA; de Winther MP
    Curr Opin Lipidol; 2014 Oct; 25(5):367-73. PubMed ID: 25188918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages: The Good, the Bad, and the Gluttony.
    Ross EA; Devitt A; Johnson JR
    Front Immunol; 2021; 12():708186. PubMed ID: 34456917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage phenotypic plasticity in atherosclerosis: The associated features and the peculiarities of the expression of inflammatory genes.
    Chistiakov DA; Bobryshev YV; Nikiforov NG; Elizova NV; Sobenin IA; Orekhov AN
    Int J Cardiol; 2015 Apr; 184():436-445. PubMed ID: 25755062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic pathways in macrophages emerge as novel targets in atherosclerosis.
    Neele AE; Van den Bossche J; Hoeksema MA; de Winther MP
    Eur J Pharmacol; 2015 Sep; 763(Pt A):79-89. PubMed ID: 26004034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory Therapeutic Effects of Curcumin on M1/M2 Macrophage Polarization in Inflammatory Diseases.
    Abdollahi E; Johnston TP; Ghaneifar Z; Vahedi P; Goleij P; Azhdari S; Moghaddam AS
    Curr Mol Pharmacol; 2023; 16(1):2-14. PubMed ID: 35331128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution therapy: Harnessing efferocytic macrophages to trigger the resolution of inflammation.
    Saas P; Vetter M; Maraux M; Bonnefoy F; Perruche S
    Front Immunol; 2022; 13():1021413. PubMed ID: 36389733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease.
    Pons D; de Vries FR; van den Elsen PJ; Heijmans BT; Quax PH; Jukema JW
    Eur Heart J; 2009 Feb; 30(3):266-77. PubMed ID: 19147603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Mechanisms in Monocytes/Macrophages Regulate Inflammation in Cardiometabolic and Vascular Disease.
    Davis FM; Gallagher KA
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):623-634. PubMed ID: 30760015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.
    Marquardt V; Theruvath J; Pauck D; Picard D; Qin N; Blümel L; Maue M; Bartl J; Ahmadov U; Langini M; Meyer FD; Cole A; Cruz-Cruz J; Graef CM; Wölfl M; Milde T; Witt O; Erdreich-Epstein A; Leprivier G; Kahlert U; Stefanski A; Stühler K; Keir ST; Bigner DD; Hauer J; Beez T; Knobbe-Thomsen CB; Fischer U; Felsberg J; Hansen FK; Vibhakar R; Venkatraman S; Cheshier SH; Reifenberger G; Borkhardt A; Kurz T; Remke M; Mitra S
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36639156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising landscape for regulating macrophage polarization: epigenetic viewpoint.
    Zhou D; Yang K; Chen L; Zhang W; Xu Z; Zuo J; Jiang H; Luan J
    Oncotarget; 2017 Aug; 8(34):57693-57706. PubMed ID: 28915705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions.
    Hoeksema MA; Gijbels MJ; Van den Bossche J; van der Velden S; Sijm A; Neele AE; Seijkens T; Stöger JL; Meiler S; Boshuizen MC; Dallinga-Thie GM; Levels JH; Boon L; Mullican SE; Spann NJ; Cleutjens JP; Glass CK; Lazar MA; de Vries CJ; Biessen EA; Daemen MJ; Lutgens E; de Winther MP
    EMBO Mol Med; 2014 Sep; 6(9):1124-32. PubMed ID: 25007801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone Deacetylase9 Represents the Epigenetic Promotion of M1 Macrophage Polarization and Inflammatory Response via TLR4 Regulation.
    Cao X; Zhang M; Li H; Chen K; Wang Y; Yang J
    Biomed Res Int; 2022; 2022():7408136. PubMed ID: 35941971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Macrophage activation in atherosclerosis. Message 2. Effects of factors on macrophage activation].
    Nikiforov NG; Elizova NV; Nikitina NA; Karagodin VP; Orekhov AN
    Patol Fiziol Eksp Ter; 2016; 60(1):59-64. PubMed ID: 29215250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of prostaglandin E2 in macrophage polarization: Insights into atherosclerosis.
    Wang W; Liang M; Wang L; Bei W; Rong X; Xu J; Guo J
    Biochem Pharmacol; 2023 Jan; 207():115357. PubMed ID: 36455672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6.
    Zhang Q; Zhao K; Shen Q; Han Y; Gu Y; Li X; Zhao D; Liu Y; Wang C; Zhang X; Su X; Liu J; Ge W; Levine RL; Li N; Cao X
    Nature; 2015 Sep; 525(7569):389-393. PubMed ID: 26287468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.